Alumnus Gregor Strobbe propels global epilepsy research into the future

(08-02-2021) For the second year in a row, the Flemish start-up Epilog has been nominated for the prestigious Rising Star Award of Deloitte's Technology Fast 50.

And this is because their technology is pioneering the treatment of epilepsy. Hence, Epilog is increasingly appearing in the world's largest epilepsy research centres.

On Bloovi's website, CEO and co-founder Gregor Strobbe unfolds his future plans: "We want to use our technology to advance research into other brain disorders, such as dementia, migraines, brain infarcts,...".

Epilog was founded four years ago as a spin-off of Ghent University, Antwerp and the research centre imec. "But our origins go all the way back to the end of the 1980s, when Professor Paul Boon of the neurology department at UZ Gent started a research project on EEG analysis in epilepsy with engineers at Ghent University," says Gregor Strobbe, an alumnus of our faculty.

Read the full article